Oramed Pharmaceuticals Inc. (ORMP): Price and Financial Metrics
ORMP Price/Volume Stats
Current price | $2.33 | 52-week high | $5.25 |
Prev. close | $2.27 | 52-week low | $1.67 |
Day low | $2.25 | Volume | 59,500 |
Day high | $2.40 | Avg. volume | 169,894 |
50-day MA | $2.89 | Dividend yield | N/A |
200-day MA | $2.67 | Market Cap | 94.41M |
ORMP Stock Price Chart Interactive Chart >
Oramed Pharmaceuticals Inc. (ORMP) Company Bio
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company was founded in 2002 and is based in Jerusalem, Israel.
Latest ORMP News From Around the Web
Below are the latest news stories about ORAMED PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ORMP as an investment opportunity.
Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year agoInvesting in stocks comes with the risk that the share price will fall. And there's no doubt that Oramed... |
ORMP: Distribution Deals, JVs in Anticipation of Commercializing ORMD-0801By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT JV with HTIT to help commercialize ORMD–0801 … Oramed Pharmaceuticals (NASDAQ:ORMP) continues to advance its proprietary oral protein delivery platform and is researching the technology potentially to treat diabetes, NASH (nonalcoholic steatohepatitis (NASH), and obesity, as an appetite suppressant, and a COVID vaccine, among other |
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding CompanySorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the consummation on September 21, 2023, of the previously announced sale to Scilex Holding Company (Nasdaq: SCLX, "Scilex") of certain securities that Sorrento held in Scilex. |
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding CompanyOramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex") entered into a Securities Purchase Agreement pursuant to which Scilex issued a Senior Secured Promissory Note (the "Note") to Oramed. The Note is the culmination of Scilex's assumption of Sorrento Therapeutics Inc.'s ("Sorrento") approximately $100 million senior secured Debtor In Possession ("DIP") term loan facility with Oramed. Oramed previously annou |
Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.PALO ALTO, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, announced the consummation of the previously announced purchase of securities from Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”). Pursuant to that certain Stock Purchase Agreement entered into on Septem |
ORMP Price Returns
1-mo | -19.93% |
3-mo | 2.64% |
6-mo | 26.63% |
1-year | 2.64% |
3-year | -76.18% |
5-year | -38.68% |
YTD | 0.87% |
2023 | -80.80% |
2022 | -15.76% |
2021 | 236.79% |
2020 | -17.67% |
2019 | 71.67% |
Continue Researching ORMP
Want to see what other sources are saying about Oramed Pharmaceuticals Inc's financials and stock price? Try the links below:Oramed Pharmaceuticals Inc (ORMP) Stock Price | Nasdaq
Oramed Pharmaceuticals Inc (ORMP) Stock Quote, History and News - Yahoo Finance
Oramed Pharmaceuticals Inc (ORMP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...